Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Clorox suffered after the pandemic with slowing sales and a painful transition to a new CRM system. The drop has made the dividend yield and valuation increasingly compelling.

Jenny Harrington, CEO of Gilman Hill Asset Management, told CNBC she is buying Clorox now, arguing the stock looks undervalued relative to its long‑term history. Consumer staples have been the worst‑performing sector in the S&P 500 this month, but Harrington said the pullback is creating an attractive entry point.

CLX drives growth with innovation and digital upgrades, positioning its international expansion as a key long-term lever.

LVO, MU and CLX highlight how Zacks strategies and portfolio picks are delivering strong gains despite recent market volatility.

Dividend Aristocrats, tracked via NOBL, outperformed SPY YTD despite a sharp March pullback, with 44 Aristocrats beating SPY and 17 posting double-digit gains. Momentum, valuation (via dividend yield theory), and projected long-term total return now guide Aristocrat selection, with 39 currently screening as undervalued and offering ≥10% expected annualized returns. Recent dividend increases from CL, GD, LIN, and O bring the 2026 average Aristocrat dividend growth rate to 3.40%, with Realty Income expected to announce further hikes throughout the year.

Realty Income offers a rock-solid customer base and generous monthly dividends. A downbeat stock and a relatively high-yield dividend point to an opportunity in Clorox.

CLX navigates ERP disruption and macro headwinds while advancing digital transformation to drive efficiency and margin gains.